Poziotinib

Synonyms: HM781-36B, NOV120101

Poziotinib is an irreversible pan-HER inhibitor with IC50 of 3.2 nM, 5.3 nM and 23.5 nM for HER1, HER2, and HER4, respectively. Poziotinib also induces apoptosis and G1 cell cycle arrest. Phase 2.

Poziotinib Chemical Structure

Poziotinib Chemical Structure

CAS: 1092364-38-9

Selleck's Poziotinib has been cited by 28 publications

Purity & Quality Control

Batch: Purity: 99.37%
99.37

Poziotinib Related Products

Signaling Pathway

Choose Selective EGFR Inhibitors

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
A431 Antiproliferative assay 72 hrs Antiproliferative activity against human A431 cells expressing wild type EGFR incubated for 72 hrs by MTS assay, IC50 = 0.0009 μM. 28754471
SKBR3 Antiproliferative assay 72 hrs Antiproliferative activity against human SKBR3 cells expressing wild type HER2 incubated for 72 hrs by MTS assay, IC50 = 0.001 μM. 28754471
Ba/F3 Function assay Inhibition of human EGFR T790M/L858R mutant expressed in mouse Ba/F3 cells, IC50 = 0.0022 μM. 28754471
insect cells Function assay Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells, IC50 = 0.0032 μM. 28754471
Ba/F3 Function assay Inhibition of human EGFR T790M mutant expressed in mouse Ba/F3 cells, IC50 = 0.0042 μM. 28754471
insect cells Function assay Inhibition of GST-tagged human HER2 catalytic domain expressed in insect cells, IC50 = 0.0053 μM. 28754471
NCI-H1975 Antiproliferative assay 72 hrs Antiproliferative activity against human NCI-H1975 cells expressing EGFR T790M/L858R mutant incubated for 72 hrs by MTS assay, IC50 = 0.0057 μM. 28754471
HS27 Antiproliferative assay 72 hrs Antiproliferative activity against human HS27 cells expressing wild type HER2 incubated for 72 hrs by MTS assay, GI50 = 3.83 μM. 28754471
SKBR3 Anticancer assay 72 hrs Anticancer activity against Erb-B2 overexpressing human SKBR3 cells assessed as cell growth inhibition after 72 hrs by SRB assay, ID50 = 0.0003 μM. ChEMBL
A431 Anticancer assay 72 hrs Anticancer activity against EGFR overexpressing human A431 cells assessed as cell growth inhibition after 72 hrs by SRB assay, ID50 = 0.0004 μM. ChEMBL
Sf21 Function assay 10 mins Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization, IC50 = 0.0013 μM. ChEMBL
NCI-H1975 Anticancer assay 48 hrs Anticancer activity against human NCI-H1975 cells assessed as cell growth inhibition after 48 hrs by celltiter one shot solution assay, IC50 = 0.0027 μM. ChEMBL
Sf21 Function assay 10 mins Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarizat, IC50 = 0.0044 μM. ChEMBL
Click to View More Cell Line Experimental Data

Biological Activity

Description Poziotinib is an irreversible pan-HER inhibitor with IC50 of 3.2 nM, 5.3 nM and 23.5 nM for HER1, HER2, and HER4, respectively. Poziotinib also induces apoptosis and G1 cell cycle arrest. Phase 2.
Targets
HER1 [1]
(Cell-free assay)
HER2 [1]
(Cell-free assay)
HER4 [1]
(Cell-free assay)
3.2 nM 5.3 nM 23.5 nM
In vitro
In vitro Poziotinib specifically inhibits the cell growth in HER2 amplified gastric cancer cells, and inhibits the phosphorylation of EGFR and key components of downstream signaling cascades such as STAT3, AKT and ERK. Poziotinib also induces apoptosis and G1 cell cycle arrest by activating the mitochondrial pathway in HER2 amplified gastric cancer cells. Furthermore, Poziotinib also exerts synergistic effects with chemotherapeutic agents in both HER2 amplified and HER2 non-amplified gastric cancer cells. [1]
Kinase Assay Enzyme activity assay
To determine the IC50 values of HM781-36B for kinase inhibition, enzymes of EGFR, HER2, and HER4 are expressed as recombinant proteins in Sf9 insect cells. Enzyme selectivity screening is then performed using a tyrosine kinase assay kit. Briefly, the reactions are performed in 96 well polystyrene round-bottomed plates containing kinase buffer composed of 100 mM HEPES (pH 7.4), 25 mM MgCl2, 10 mM MnCl2 and 250 μM Na3VO4. The reactions are initiated by the addition of 100 ng/assay enzyme, 100 μM ATP, and 10 ng/mL poly(Glu, Tyr). After 1 h of incubation at room temperature, the reactions are terminated by adding 6 mM EDTA solution and then anti-phosphotyrosine antibody, PTK Green Tracer, and FP dilution buffer mixtures. The fluorescence polarization values are then measured after 30 min at room temperature using a Victor3 microplate reader. Finally, the IC50 values were calculated using the following equation: Y = bottom + (top–bottom)/(1 + 10(X-logIC50)).
Cell Research Cell lines Gastric cancer cell lines (SNU-1, 5, 16, 216, 484, 601, 620, 638, 668, 719, N87 and AGS)
Concentrations ~10 μM
Incubation Time 72 hours
Method Viable cell growth is determined by an MTT reduction assay. Briefly, all cell lines are seeded at a density of 3 × 103 per well in 96-well culture plates and then incubated at 37 °C for 24 h. The cells are then treated with 0.001, 0.01, 0.1, or 10 μM of HM781-36B. Three days later, 50 μg of MTT are added to each well and the samples are then incubated for 4 h to reduce the dye. Next, the samples are treated with DMSO, after which the absorbance of the converted dye in the living cells is measured at a wavelength of 540 nm. Six replicate wells are used for each analysis, and at least three independent experiments are conducted. Data points shown represent the mean while bars represent the SE.
Experimental Result Images Methods Biomarkers Images PMID
Western blot Cleaved caspase-3 / Cleaved caspase-9 / PARP / Bcl-2 pEGFR / EGFR / pHER2 / HER2 / BMX / pERK / ERK / pAKT / AKT 25761479
Growth inhibition assay Cell viability 25761479
In Vivo
In vivo In nude mice bearing N87 human gastric cancer xenografts, Poziotinib (0.5 mg/kg p.o.) alone significantly inhibits the growth of tumors, and coadministraion of Poziotinib and 5-FU causes more effective tumor inhibition. [1] In addition, HM781-36B shows excellent antitumor activity in a variety of EGFR- and HER-2-dependent tumor xenograft models, including erlotinib-sensitive HCC827 NSCLC cells, erlotinib-resistant NCI-H1975 NSCLC cells, HER-2 overexpressing Calu-3 NSCLC cells, NCI-N87 gastric cancer cells, SK-Ov3 ovarian cancer cells and EGFR-overexpressing A431 epidermoid carcinoma cancer cells. [2]
Animal Research Animal Models BALB/c athymic nude mice bearing N87 xenografts
Dosages 0.5 mg/kg daily
Administration p.o.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04436562 Completed
Healthy
Spectrum Pharmaceuticals Inc
May 29 2020 Phase 1
NCT03804515 Terminated
Solid Tumor
Spectrum Pharmaceuticals Inc
June 25 2019 Phase 1

Chemical Information & Solubility

Molecular Weight 491.34 Formula

C23H21Cl2FN4O3

CAS No. 1092364-38-9 SDF Download Poziotinib SDF
Smiles COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 98 mg/mL ( (199.45 mM); Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Poziotinib | Poziotinib supplier | purchase Poziotinib | Poziotinib cost | Poziotinib manufacturer | order Poziotinib | Poziotinib distributor